No retraction, correction or concern found when last checked on Oct 18, 2026.

Causes and Consequences of Snake Venom Variation

Nicholas R. Casewell, Timothy N.W. Jackson, Andreas H. Laustsen and 1 more

Trends in Pharmacological Sciences · 2020 · Review · CC BY

doi:10.1016/j.tips.2020.05.006

Abstract

Snake venoms are mixtures of toxins that vary extensively between and within snake species. This variability has serious consequences for the management of the world's 1.8 million annual snakebite victims. Advances in 'omic' technologies have empowered toxinologists to comprehensively characterize snake venom compositions, unravel the molecular mechanisms that underpin venom variation, and elucidate the ensuing functional consequences. In this review, we describe how such mechanistic processes have resulted in suites of toxin isoforms that cause diverse pathologies in human snakebite victims and we detail how variation in venom composition can result in treatment failure. Finally, we outline current therapeutic approaches designed to circumvent venom variation and deliver next-generation treatments for the world's most lethal neglected tropical disease.

References 90

1.
The Diversity of Venom: The Importance of Behavior and Venom System Morphology in Understanding Its Ecology and Evolution · 2019
No notice
2.
Dowell NL, et al. The deep origin and recent loss of venom toxin genes in rattlesnakes. Curr Biol. 2016;26:2434-2445.
Not in our library10.1016/j.cub.2016.07.038
3.
Post Y, et al. Snake venom gland organoids. Cell. 2020;180:233-247.
Not in our library10.1016/j.cell.2019.11.038
4.
Casewell NR, et al. Solenodon genome reveals convergent evolution of venom in eulipotyphlan mammals. Proc Natl Acad Sci U S A. 2019;116:25745-25755.
Not in our library10.1073/pnas.1906117116
5.
Sunagar K, et al. Cell type-specific expression profiling unravels the development and evolution of stinging cells in sea anemone. BMC Biol. 2018;16:108.
Not in our library10.1186/s12915-018-0578-4
6.
Columbus-Shenkar YY, et al. Dynamics of venom composition across a complex life cycle. Elife. 2018;7:e35014.
Not in our library10.7554/elife.35014
7.
Clark GC, et al. Friends or foes? Emerging impacts of biological toxins. Trends Biochem Sci. 2019;44:365-379.
Not in our library10.1016/j.tibs.2018.12.004
8.
Jackson TNW, et al. Endless forms most beautiful: the evolution of ophidian oral glands, including the venom system, and the use of appropriate terminology for homologous structures. Zoomorphology. 136;107-130.
Not in our library
9.
Jackson K, et al. The evolution of venom-delivery systems in snakes. Zool J Linnean Soc. 137;337-354.
Not in our library
10.
Gutérrez K, et al. Snakebite envenoming. Nat Rev Dis Primers. 3;1-21.
Not in our library10.1038/nrdp.2017.79
11.
Snakebite envenomation turns again into a neglected tropical disease! · 2017
No notice
12.
Massey DJ, et al. Venom variability and envenoming severity outcomes of the Crotalus scutulatus (Mojave rattlesnake) from Southern Arizona. J Proteome. 2012;75:2576-2587.
Not in our library10.1016/j.jprot.2012.02.035
13.
Casewell NR, et al. Medically importantdifferences in snake venom composition are dictated by distinct postgenomic mechanisms. Proc Natl Acad Sci U S A. 2014;111:9205-9210.
Not in our library10.1073/pnas.1405484111
14.
Durban J, et al. Integrated venomics and venom gland transcriptome analysis of juvenile and adult Mexican rattlesnakes Crotalus simus, and C. culminatus revealed miRNA-modulated ontogenetic shifts. J Proteome Res. 2017;16:3370-3390.
Not in our library10.1021/acs.jproteome.7b00414
15.
Pla D, et al. Phylovenomics of Daboia russelii across the Indian subcontinent. Bioactivities and comparative in vivo neutralization and in vitro third-generation antivenomics of antivenoms against venoms from India, Bangladesh and Sri Lanka. J Proteome. 2019;207:103443.
Not in our library10.1016/j.jprot.2019.103443
16.
Beyond the ‘big four’: Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies · 2019
No notice
17.
Jackson TN, et al. Rapid radiations and the race to redundancy: an investigation of the evolution of Australian elapid snake venoms. Toxins Basel. 2016;8:309.
Not in our library10.3390/toxins8110309
18.
A Tricky Trait: Applying the Fruits of the “Function Debate” in the Philosophy of Biology to the “Venom Debate” in the Science of Toxinology · 2016
Not checked
19.
Williams DJ, et al. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa. J Proteome. 2011;74:1735-1767.
Not in our library10.1016/j.jprot.2011.05.027
20.
A Review and Database of Snake Venom Proteomes · 2017
No notice
21.
Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming · 2019
No notice
22.
Jackson TN, et al. Snake venom in context: neglected clades and concepts. Front Ecol Evol. 2019;7:332.
Not in our library
23.
Holding ML, et al. Coevolution of venom function and venom resistance in a rattlesnake predator and its squirrel prey. Proc R Soc B Biol Sci. 2016;283:20152841.
Not in our library10.1098/rspb.2015.2841
24.
Ji XH, et al. Receptor variability-driven evolution of snake toxins. Zool Res. 2018;283:431-436.
Not in our library10.24272/j.issn.2095-8137.2018.063
25.
Daltry JC, et al. Diet and snake venom evolution. Nature. 1996;379:537-540.
Not in our library10.1038/379537a0
26.
Jorge da Silva N, Aird SD. Prey specificity, comparative lethality and compositional differences of coral snake venoms. Comp Biochem Physiol C Toxicol Pharmacol. 2001;128:425-456.
Not in our library10.1016/s1532-0456(00)00215-5
27.
Barlow A, et al. Coevolution of diet and prey-specific venom activity supports the role of selection in snake venom evolution. Proc Biol Sci. 2009;276:2443-2449.
Not in our library10.1098/rspb.2009.0048
28.
Fry BG, et al. The structural and functional diversification of the Toxicofera reptile venom system. Toxicon. 2012;60:434-448.
Not in our library10.1016/j.toxicon.2012.02.013
29.
Ainsworth S, et al. The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms. Commun Biol. 2018;1:1-14.
Not in our library10.1038/s42003-018-0039-1
30.
Aird SD, et al. Population genomic analysis of a pitviper reveals microevolutionary forces underlying venom chemistry. Genome Biol Evol. 2017;9:2640-2649.
Not in our library10.1093/gbe/evx199
31.
Lewontin RC, et al. The units of selection. Annu Rev Ecol Syst. 1970;1:1-18.
Not in our library
32.
Smiley-Walters SA, et al. High levels of functional divergence in toxicity towards prey among the venoms of individual pigmy rattlesnakes. Biol Lett. 2019;15:20180876.
Not in our library10.1098/rsbl.2018.0876
33.
Petras D, et al. Intact protein mass spectrometry reveals intraspecies variations in venom composition of a local population of Vipera kaznakovi in Northeastern Turkey. J Proteome. 2019;199:31-50.
Not in our library10.1016/j.jprot.2019.02.004
34.
Reyes-Velasco J, et al. Expression of venom gene homologs in diverse python tissues suggests a new model for the evolution of snake venom. Mol Biol Evol. 2015;32:173-183.
Not in our library10.1093/molbev/msu294
35.
Casewell NR, et al. Complex cocktails: the evolutionary novelty of venoms. Trends Ecol Evol. 2013;28:219-229.
Not in our library10.1016/j.tree.2012.10.020
36.
Fry BG, et al. Molecular evolution and phylogeny of elapid snake venom three-finger toxins. J Mol Evol. 2003;57:110-129.
Not in our library10.1007/s00239-003-2461-2
37.
Ohno S, et al. Evolution by Gene Duplication. Springer-Verlag. 1970.
Not in our library
38.
Koludarov I, et al. Family saga: reconstructing the evolutionary history of a functionally diverse gene family reveals complexity at the genetic origins of novelty. bioRxiv. 2019.
Not in our library10.1101/583344
39.
Vonk FJ, et al. The king cobra genome reveals dynamic gene evolution and adaptation in the snake venom system. Proc Natl Acad Sci. 2013;110:20651-20656.
Not in our library10.1073/pnas.1314702110
40.
Moran Y, et al. Concerted evolution of sea anemone neu-rotoxin genes is revealed through analysis of the Nematostella vectensis genome. Mol Biol Evol. 2008;25:737-747.
Not in our library10.1093/molbev/msn021
41.
Margres MJ, et al. Selection to increase expression, not sequence diversity, precedes gene family origin and expansion in rattlesnake venom. Genetics. 2017;206:1569-1580.
Not in our library10.1534/genetics.117.202655
42.
Shibata H, et al. The habu genome reveals accelerated evolution of venom protein genes. Sci Rep. 2018;8:1-11.
Not in our library10.1038/s41598-018-28749-4
43.
Casewell NR, et al. Domain loss facilitates accelerated evolution and neofunctionalization of duplicate snake venom metalloproteinase toxin genes. Mol Biol Evol. 2011;28:2637-2649.
Not in our library10.1093/molbev/msr091
44.
Giorgianni MW, et al. The origin and diversification of a novel protein family in venomous snakes. Proc Natl Acad Sci U S A. 2020;117:10911-10920.
Not in our library10.1073/pnas.1920011117
45.
Brust A, et al. Differential evolution and neofunctionalization of snake venom metalloprotease domains. Mol Cell Proteomics. 2013;12:651-663.
Not in our library10.1074/mcp.m112.023135
46.
Ogawa T, et al. Alternative mRNA splicing in three venom families underlyinga possible production of divergent venom proteins of the habu snake, Protobothrops flavoviridis. Toxins Basel. 2019;11:581.
Not in our library10.3390/toxins11100581
47.
Inventing an arsenal: adaptive evolution and neofunctionalization of snake venom phospholipase A2 genes. · 2007
No notice
48.
Sunagar K, et al. Evolution of CRISPs associated with toxicoferan-reptilian venom and mammalian reproduction. Mol Biol Evol. 2012;29:1807-1822.
Not in our library10.1093/molbev/mss058
49.
Župunski V, Kordiš D, et al. Strong and widespread action of site-specific positive selection in the snake venom Kunitz/BPTI protein family. Sci Rep. 2016;6:37054.
Not in our library10.1038/srep37054
50.
Fry BG, et al. The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms. Annu Rev Genomics Hum Genet. 2009;10:483-511.
Not in our library10.1146/annurev.genom.9.081307.164356
51.
Kini RM, Chan YM. Accelerated evolution and molecular surface of venom phospholipase A 2 enzymes. J Mol Evol. 1999;48:125-132.
Not in our library10.1007/pl00006450
52.
Three-Fingered RAVERs: Rapid Accumulation of Variations in Exposed Residues of Snake Venom Toxins · 2013
No notice
53.
The Rise and Fall of an Evolutionary Innovation: Contrasting Strategies of Venom Evolution in Ancient and Young Animals · 2015
No notice
54.
Cardoso FC, et al. Multifunctional toxins in snake venoms and therapeutic implications: from pain tohemorrhage and necrosis. Front Ecol Evol. 2019;7:218.
Not in our library
55.
Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise · 2017
No notice
56.
Warrell DA. Snake venoms in science and clinical medi-cine. 1. Russell’s viper: biology, venom and treatment of bites. Trans R Soc Trop Med Hyg. 1989;83:732-740.
Not in our library10.1016/0035-9203(89)90311-8
57.
Zancolli G, et al. When one phenotype is not enough: divergent evolutionary trajectories govern venom variation in a widespread rattlesnake species. Proc Biol Sci. 2019;286:20182735.
Not in our library10.1098/rspb.2018.2735
58.
Laustsen AH, et al. Exploration of immunoglobulin transcriptomes from mice immunized with three-finger toxins and phospholipases A(2) from the Central American coral snake,Micrurus nigrocinctus. PeerJ. 2017;5:e2924.
Not in our library10.7717/peerj.2924
59.
Leon G, et al. Current technology for the industrial manufacture of snake antivenoms. Toxicon. 2018;151:63-73.
Not in our library10.1016/j.toxicon.2018.06.084
60.
Whiteley G, et al. Defining the pathogenic threat of envenoming by South African shield-nosed and coral snakes (genus Aspidelaps), and revealing the likely efficacy of available antivenom. J Proteome. 2019;198:186-198.
Not in our library10.1016/j.jprot.2018.09.019
61.
Visser L, et al. Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance. Trans R Soc Trop Med Hyg. 2008;102:445-450.
Not in our library10.1016/j.trstmh.2007.11.006
62.
Alirol E, et al. Antivenoms for snakebite envenoming: what is in the research pipeline? PLoS Negl Trop Dis. 2015;9:e0003896.
Not in our library10.1371/journal.pntd.0003896
63.
Evaluation of the geographical utility of Eastern Russell's viper (Daboia siamensis) antivenom from Thailand and an assessment of its protective effects against venom-induced nephrotoxicity. · 2019
Not checked
64.
Calvete JJ, et al. Toxin-resolved antivenomics-guided assessment of the immunorecognition landscape of antivenoms. Toxicon. 2018;148:107-122.
Not in our library10.1016/j.toxicon.2018.04.015
65.
Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial. · 2019
Not checked
66.
Harrison RA, et al. Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa. PLoS Negl Trop Dis. 2017;11:e0005969.
Not in our library10.1371/journal.pntd.0005969
67.
Harrison RA, et al. The time is now: a call for action to translate recent momentum on tackling tropical snakebite into sustained benefit for victims. Trans R Soc Trop Med Hyg. 2019;113:835-838.
Not in our library10.1093/trstmh/try134
68.
Pucca MB, et al. History of envenoming therapy and current perspectives. Front Immunol. 2019;10:1598.
Not in our library10.3389/fimmu.2019.01598
69.
Kini RM, et al. Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims. Toxins (Basel). 2018;10:534.
Not in our library10.3390/toxins10120534
70.
Laustsen AH, et al. Guiding recombinant antivenom develop-ment by omics technologies. New Biotechnol. 2018;45:19-27.
Not in our library10.1016/j.nbt.2017.05.005
71.
Laustsen AH, et al. Selecting key toxins for focused de-velopment ofelapid snake antivenoms and inhibitors guided by a toxicity score. Toxicon. 2015;104:43-45.
Not in our library10.1016/j.toxicon.2015.07.334
72.
Laustsen AH, et al. From fangs to pharmacology: the future of snakebite envenoming therapy. Curr Pharm Des. 2016;22:5270-5293.
Not in our library10.2174/1381612822666160623073438
73.
Bermúdez-Méndez E, et al. Innovative immunization strategies for antivenom development. Toxins (Basel). 2018;10:452.
Not in our library10.3390/toxins10110452
74.
de la Rosa G, et al. Horse immunization with shortchain consensus α-neurotoxin generates antibodies against broad spectrum of elapid venomous species. Nat Commun. 2019;10:3642.
Not in our library10.1038/s41467-019-11639-2
75.
Laustsen AH, et al. In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies. Nat Commun. 2018;9:3928.
Not in our library10.1038/s41467-018-06086-4
76.
Laustsen AH, et al. Unveiling the nature of black mamba (Dendroaspis polylepis) venom through venomics and antivenom immuno profiling: identification of key toxin targets for antivenom development. J Proteome. 2015;119:126-142.
Not in our library10.1016/j.jprot.2015.02.002
77.
Albulescu L-O, et al. Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite. Sci Transl Med. 2020;12.
Not in our library10.1126/scitranslmed.aay8314
78.
Layfield HJ, et al. Repurposing cancer drugs batimastat and marimastat to inhibit the activity of a group I metalloprotease from the venom of the western diamondback rattlesnake. Crotalus atrox. 2020;12:309.
Not in our library10.3390/toxins12050309
79.
Escalante T, et al. Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake. Bothrops asper Biochem. 2000;60:269-274.
Not in our library10.1016/s0006-2952(00)00302-6
80.
A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite · 2020
Corrected
81.
Gutierrez JM, et al. Varespladib (LY315920) and methyl varespladib (LY333013) abrogate or delay lethality induced by presynaptically acting neurotoxic snake venoms. Toxins. 2020;12:131.
Not in our library10.3390/toxins12020131
82.
Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation · 2016
No notice
83.
Bulfone TC, et al. Developing small molecule therapeutics for the initial and adjunctive treatment of snakebite. J Trop Med. 2018;4320175.
Not in our library10.1155/2018/4320175
84.
Knudsen C, et al. Engineering and design considerations for next-generation snakebite antivenoms. Toxicon. 2019;167:67-75.
Not in our library10.1016/j.toxicon.2019.06.005
85.
Laustsen AH. How can monoclonal antibodies be harnessed against neglected tropical diseases and other infectious diseases. Expert Opin Drug Discov. 2019;14:1103-1112.
Not in our library10.1080/17460441.2019.1646723
86.
Kessler P, et al. The three-finger toxin fold: a multifunctional structural scaffold able to modulate cholinergic functions. J Neurochem. 2017;142:7-18.
Not in our library10.1111/jnc.13975
87.
The Indian cobra reference genome and transcriptome enables comprehensive identification of venom toxins · 2020
No notice
88.
Schield DR, et al. The origins and evolution of chromosomes, dosage compensation, and mechanisms underlying venom regulation in snakes. Genome Res. 2019;29:590-601.
Not in our library10.1101/gr.240952.118
89.
Snakebite Mortality in India: A Nationally Representative Mortality Survey · 2011
No notice
90.
Simpson ID, Norris RL, et al. Snakes of medical importance in India: is the concept of the “Big 4” still relevant and useful? Wilderness Environ Med. 2007;18:2-9.
Not in our library10.1580/06-weme-co-023r1.1

Cited by papers we hold 2

In vivo and in vitro prospection of the anti-ophidic properties exercised by the extracts of Jacaranda decurrens L. · 2021
Not checked
Insights into how development and life-history dynamics shape the evolution of venom · 2021
Not checked

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.